@article{d3ab813db23e4d5997f58f9eaf56dbcf,
title = "The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin",
keywords = "Children, Enterococcus, Gram-positive infections, Resistant infections",
author = "Deville, {Jaime G.} and Johanna Goldfarb and Kaplan, {Sheldon L.} and Ozlem Equils and Huang, {David B.} and Ang, {Jocelyn Y.} and Salazar, {Juan C.}",
note = "Funding Information: M. F. was supported in this study by a grant from the Faculty of Medicine of the University of Rome {\textquoteleft}La Sapienza{\textquoteright}. Data have been generated as part of routine hospital work. Funding Information: S. L. K. has received a grant from Pfizer, Inc. for an investigator-initiated study. J. C. S. has previously participated as a paid consultant to Pfizer, Inc., but has not received any payments performing duties as a speaker on behalf of Pfizer, Inc. in any non-CME events where linezolid in paediatric patients was discussed. O. E. and D. B. H. are employees and shareholders of Pfizer, Inc. J. G. D., J. G. and J. Y. A.: none to declare. Funding Information: M. F. was on the speakers{\textquoteright} bureau for Pfizer, Novartis and Merck. M. V. was on the speakers{\textquoteright} bureau for Pfizer, Novartis, Wyeth, Merck, Gilead, Astellas and GlaxoSmithKline. M. F. and M. V. have received research grants from Pfizer and Novartis. Other authors: none to declare. Copyright: Copyright 2011 Elsevier B.V., All rights reserved.",
year = "2010",
month = aug,
day = "12",
doi = "10.1093/jac/dkq300",
language = "English (US)",
volume = "65",
pages = "2267--2270",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "10",
}